title: Potential clinical treatment for Ebola pandemic.
authors.affiliation: State Key Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences; Department of Biochemistry and Molecular Biology, Peking Union Medical College, Tsinghua University, Beijing, 100005, China.
authors.forename: Ying
authors.initials: Y
authors.lastname: Zhong
authors.forename: Jun
authors.initials: J
authors.lastname: Xu
authors.forename: TaiSheng
authors.initials: T
authors.lastname: Li
authors.forename: XueZhong
authors.initials: X
authors.lastname: Yu
authors.forename: MiaoMiao
authors.initials: M
authors.lastname: Sheng
mesh_terms: D000354:Africa, Western; D000818:Animals; D004196:Disease Outbreaks; D019142:Hemorrhagic Fever, Ebola / Q000628:therapy* / Q000821:virology; D006801:Humans; D051379:Mice; D058873:Pandemics; D012254:Ribavirin / Q000627:therapeutic use
chemical_list: D012254:Ribavirin